Childhood septic arthritis following treatment of spondylodiskitis from Serratia marcescens.
Carmichael
Kelly D
KD
University of Texas Medical Branch, Galveston, Tex 77555, USA.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000175:diagnosis / Q000382:microbiology*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002437:Cefazolin / Q000627:therapeutic use; D003951:Diagnostic Errors; D015299:Discitis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007223:Infant; D007717:Knee / Q000382:microbiology*; D008159:Lumbar Vertebrae; D008297:Male; D016868:Serratia Infections / Q000175:diagnosis*; D012706:Serratia marcescens / Q000302:isolation & purification*; D012782:Shoulder / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D002437:Cefazolin